13F Pro quality score
Rank #131 of 2,925TOP 5%
Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.
AI-extracted from the 10-Q filed 2026-08-06 — Q2 FY2026 (quarter ended June 30, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.
Q2 revenue rose 48.1% to $28.3M as pharma patient affordability revenue nearly doubled to $14.6M, lifting net income to $6.8M from $1.4M.
Financial benefit of 51 net pharma patient affordability programs launched in the prior twelve months and higher management, setup and claim processing fees
Increase in plasma donations and dollars loaded to cards as the market returned to normalized growth, offset by 46 net plasma center reductions
AI-extracted and verified against SEC EDGAR filing text. Not investment advice.
Reported revenue, net income and operating margin by fiscal year, from Paysign, Inc.'s annual filings on SEC EDGAR.
| Period | Form | Revenue | Net income | Op. marginOperating margin |
|---|---|---|---|---|
| FY 2025 | 10-K | $82.0M | $7.6M | 9.0% |
| FY 2024 | 10-K | $58.4M | $3.8M | 1.8% |
| FY 2023 | 10-K | $47.3M | $6.5M | -0.4% |
| FY 2022 | 10-K | $38.0M | $1.0M | 0.9% |
| FY 2021 | 10-K | $29.5M | $-2.7M | -9.3% |
| FY 2020 | 10-K | $24.1M | $-9.1M | -34.6% |
Ranked by quality-factor profile and overlapping institutional ownership, from the latest 13F filings and SEC financials.
Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.
Paysign, Inc. (PAYS) stock profile, AI quality score, and SEC EDGAR financial data, a Industrials sector company. 13F Pro's AI-powered ranking engine scores PAYS at 73.2/100 on a composite quality score built from its SEC filings, placing it at rank #131 of 2,925 stocks — the top 5% of the AI-ranked universe. PAYS scores in the top quartile across free cash flow (98.2), revenue growth (90.9), earnings quality (89.0). Areas of concern include revenue scale (16.3), which score below median versus the broader universe. Shareholder dilution risk is elevated at 23.7/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Paysign, Inc. reports quarterly revenue of $28.3M, net income of $6.8M, an operating margin of 24.8%. Top institutional holders of PAYS by reported 13-F value include Topline Capital Management, BlackRock, PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, based on the most recent SEC filings. PAYS trades on the Nasdaq exchange and files with the SEC under CIK 1496443. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate PAYS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Paysign, Inc. directly from SEC EDGAR.
Financials through the period ended SEC EDGAR: CIK 1496443 →